Your session is about to expire
← Back to Search
Intrasaccular Bridging System
Medical Device for Brain Aneurysm (TORNADO-US Trial)
N/A
Recruiting
Research Sponsored by EndoStream Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Subject is neurologically stable with a Hunt & Hess score of I, II, or III.
Subject is ≥18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
TORNADO-US Trial Summary
This trial will test a device to treat brain aneurysms that could help save lives.
Who is the study for?
This trial is for adults over 18 with a specific type of ruptured brain aneurysm that's wide (4-7mm) and has a dome size of at least 5mm. Participants should be neurologically stable, able to consent, and follow the study schedule. It excludes pregnant women, those with recent neurological issues or serious health conditions, certain pre-existing diseases like Moyamoya disease, allergies to Nickel/Heparin, or involvement in another clinical study.Check my eligibility
What is being tested?
The Nautilus Intrasaccular Bridging System is being tested for its safety and potential benefits in treating wide-neck ruptured brain aneurysms. The device aims to stabilize the aneurysm and prevent further bleeding into the brain.See study design
What are the potential side effects?
While not explicitly listed here, side effects may include typical risks associated with medical devices for aneurysms such as reaction to materials used in the device (like Nickel), complications from invasive procedures like bleeding or infection, and any specific reactions related to this new system.
TORNADO-US Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My brain function is stable with a mild to moderate condition.
Select...
I am 18 years old or older.
Select...
I have a recently burst brain aneurysm that is 4-7mm wide.
TORNADO-US Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The proportion of subjects experiencing death or stroke
Secondary outcome measures
Coil/Device entanglement
Distribution of parent vessel compromise
Technical Success
+3 moreTORNADO-US Trial Design
1Treatment groups
Experimental Treatment
Group I: Patients treated with the deviceExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
EndoStream MedicalLead Sponsor
1 Previous Clinical Trials
30 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a pre-existing condition that significantly affects your ability to function independently.My brain function is stable with a mild to moderate condition.You have a bulge in a blood vessel that is 5 millimeters or larger.I have a recently burst brain aneurysm that is 4-7mm wide.I am 18 years old or older.I have not had a stroke, head injury, or brain surgery in the last 6 months.I have another aneurysm that might need treatment within a year.I am a woman aged 18-55 and cannot provide a negative pregnancy test.I have serious health conditions that could increase my risk in a study.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Patients treated with the device
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many individuals are actively participating in this medical experiment?
"Affirmative. ClinicalTrials.gov holds data that indicates this trial is currently recruiting participants, beginning December 17th 2022 and most recently updated February 15 2023. It requires 45 patients to be enrolled across 1 site."
Answered by AI
Is recruitment still active for this clinical trial?
"Correct. According to the information presented on clinicaltrials.gov, this medical study is still recruiting participants; it was first uploaded on December 17th 2022 and most recently updated February 15th 2023. Up to 45 individuals are needed from a single trial site."
Answered by AI
Share this study with friends
Copy Link
Messenger